Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by stockman6767on Oct 05, 2006 7:21pm
273 Views
Post# 11469283

RE: action on hml/MDS

RE: action on hml/MDSI had a significant number of Hemosol (old) and received LPBP class A shares in the switch to Hemosol (new) which then went bankrupt. This announcement of the LPBP asset sale is of interest to any of us still holding the LPBP shares. I assume that whoever had them, still has them, as to the best of my knowledge, they are not traded on any public market. They said this would be paid to shareholders. Do you know how much of a payout this means (per share) for the 1.3 Billion dollar receipts to shareholders (or is it .75B $)? Do you know if LPBP has an investor relations number to get more info? Thank for the help.
Bullboard Posts